To include your compound in the COVID-19 Resource Center, submit it here.

PreCision Dermatology, Valeant Pharmaceuticals deal

Valeant will acquire dermatology company PreCision for $475 million in cash, plus up to an additional $25

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE